ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $237,000 | +33.1% | 1,372 | -2.5% | 0.01% | +25.0% |
Q2 2021 | $178,000 | -7.3% | 1,407 | -0.4% | 0.00% | 0.0% |
Q1 2021 | $192,000 | +23.1% | 1,413 | +15.6% | 0.00% | -33.3% |
Q4 2020 | $156,000 | +32.2% | 1,222 | +15.0% | 0.01% | -14.3% |
Q3 2020 | $118,000 | – | 1,063 | – | 0.01% | – |
Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 21 | +40.0% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 15 | -53.1% | 0.00% | – |
Q4 2015 | $2,000 | – | 32 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |